Cambrian BioPharma Inc
Pharmaceutical company · New York, United States
Cambrian BioPharma Inc is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $23 million sold in a notice filed in 2025.
Cambrian BioPharma at a glance
What does Cambrian BioPharma do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $23 million sold (2025).
Frequently asked questions about Cambrian BioPharma
Where is Cambrian BioPharma headquartered?
Cambrian BioPharma Inc is headquartered in New York, United States.
What does Cambrian BioPharma do?
Cambrian BioPharma Inc is a pharmaceutical company.
When was Cambrian BioPharma founded?
The earliest incorporation on record for Cambrian BioPharma Inc is in 2019, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences